Nature Biotechnology
Last updated ISSN 0733-222X
Nature Biotechnology is published by Nature Portfolio in medicine. It is a subscription journal. The article processing charge is $12,690.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Nature Biotechnology is — and show you journals like it.
What it publishes
Recent work in Nature Biotechnology concentrates on these topics, taken from its published record rather than from its own description:
- Biotechnology and Related Fields
- Science, Research, and Medicine
- CRISPR and Genetic Engineering
- Biomedical Ethics and Regulation
- RNA and protein synthesis mechanisms
- Monoclonal and Polyclonal Antibodies Research
- Transgenic Plants and Applications
- Genetically Modified Organisms Research
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
Key facts
| Publisher | Nature Portfolio |
|---|---|
| ISSN | 0733-222X, 1087-0156, 1546-1696, 2331-3684 |
| Subject area | Medicine |
| Access | Subscription |
| Article processing charge | $12,690 |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus |
| Articles published | 20,235 |
| Publishing since | 1941 |
| Journal website | www.nature.com/nbt |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Nature Biotechnology
Other established journals in medicine, if this one is not the right home for your paper: